Prevention & Chronic Conditions


Cardiovascular disease (CVD) is a significant and ever-growing problem in the UK, accounting for nearly one-third of all deaths and leading to significant morbidity. Globally CVD accounts for 31% of mortality, mainly from heart disease and cerebrovascular accident.

The burden of CVD can be ameliorated by careful risk modification and primary prevention is an important priority for all developers of health policy. Strong consensus exists between international guidelines regarding the necessity of smoking cessation, weight optimisation and exercise, although guidelines have slightly different approaches to hypertension and vary considerably regarding their approach to optimal lipid profile, which remains a contentious issue.

Related Articles


Pharmacological Treatment of Type 2 Diabetes and CVD

Felipe Martínez,


Citation: European Cardiology Review 2021;16:e12.

Type 2 Diabetes Treatment in Patients with CVD

Tariq Ahmad, Ralph J Riello, Silvio Inzucchi,


Citation: European Cardiology Review 2021;16:e11.

Editorial: The EXCEL Trial

Pablo Avanzas, Juan Carlos Kaski,


Citation: European Cardiology Review 2021;16:e09.

Renin–Angiotensin–Aldosterone System and COVID-19

Eliecer Coto, Pablo Avanzas, Juan Gómez,


Citation: European Cardiology Review 2021;16:e07.